Botanical species · safety record

Melaleuca cajuputi

The EFSA Compendium of Botanicals holds 10 constituent measurements for Melaleuca cajuputi. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Melaleuca cajuputi Powell

10Constituent measurements

0Safety records

5Cited sources

45Licensed products (Canada)

Also recorded as

Melaleuca cajuputi subsp. cajuputi

Synonyms are carried from the source compendium. A species may be traded and studied under more than one name, which is exactly how a safety record gets lost.

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 45 licensed products naming Melaleuca cajuputi as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Source material stated

Essential oil from leaf
Fresh leaves
Leaf
Leaf/Leaves
Leaves
Melaleuca cajuputi - Twig Leafy
Twig leafy
Twigs

What the records describe

Constituents measured

Plant parts

Preparations

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
1,8-cineole	Leaves	Essential oil	43.7 Percent	GC-MS	Resolve DOI
Tannins	Stem / stalk	Solvent extraction	98.8 Milligram/gram	High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)	Resolve DOI
1,8-cineole	Leaves	Essential oil	≤ 60.2 Percent	Gaschromatography (GC)	No resolvable identifier
1,8-cineole	Live plants	Essential oil	65.2 Percent	Unspecified	No resolvable identifier
1,8-cineole	Leaves	Essential oil	≥ 42.7 Percent	Gaschromatography (GC)	No resolvable identifier
Eugenol	Leaves	Solvent extraction	≥ 0.4 Percent	GC-FID	No resolvable identifier
Eugenol	Leaves	Solvent extraction	≤ 1.2 Percent	GC-FID	No resolvable identifier
Methyleugenol	Leaves	Solvent extraction	≥ 0.2 Percent	GC-FID	No resolvable identifier
Methyleugenol	Leaves	Solvent extraction	≤ 1.3 Percent	GC-FID	No resolvable identifier
Myrcene	Live plants	Essential oil	0.9 Percent	Unspecified	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Susanto, M., Doran, J., Arnold, R., Rimbawanto, A. Genetic variation in growth and oil characteristics of Melaleuca cajuputi subsp cajuputi and potential for genetic improvement . Journal of tropical forest science, 2003, vol. 15, no. 3, p. 469-482.
Silva, Cleber J., Barbosa, Luiz C. A., Maltha, Ulia R. A., Pinheiro, Antonio L., Ismail, Fyaz M. D. Comparative study of the essential oils of seven Meialeuca (Myrtaceae) species grown in Brazil. FLAVOUR AND FRAGRANCE JOURNAL, 2007, vol. 22, no. 6, p. 474-478. DOI
Galle-Hoffmann, Ute., Konig, Wilfried A. Essential oils. Part 3. Additional tea tree oils from Melaleuca. Deutsche apotheker zeitung, 1999, p. 59-62.
Jajaei, S. M., Daud, W. R. W., Markom, M., Zakaria, Z., Lo Presti, M., Costa, Rosaria., Mondello, L., Santi, Luca. Extraction of Melaleuca cajuputi Using Supercritical Fluid Extraction and Solvent Extraction. JOURNAL OF ESSENTIAL OIL RESEARCH, 2010, vol. 22, no. 3, p. 205-210.
Batubara, I., Kotsuka, S., Yamauchi, K., Kuspradini, H., Mitsunaga, T., Darusman, L.K. TNF-alpha production inhibitory activity, phenolic, flavonoid and tannin contents of selected Indonesian medicinal plants. Research Journal of Medicinal Plant, 2012, vol. 6, no. 6, p. 406-415. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature